2nd Department of Medicine Department of Cardiovascular Medicine 1st Faculty of Medicine Charles University and General University Hospital Prague 2 Czech Republic

Charles University and General University Hospital Institute of pathology Prague 2 Czech Republic

Zobrazit více v PubMed

Ammirati E, Moslehi JJ. Diagnosis and treatment of acute myocarditis: A review. JAMA 2023;329:1098‐1113. doi: 10.1001/jama.2023.3371 PubMed DOI

Nieman, K L. Treatment of adrenal insufficiency in adults. In: Post, TW (Ed), UpToDate, Waltham, MA, 2022. doi: 10.1002/EHF2.15001 DOI

Caforio AL, Pankuweit S, Arbustini E. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2013;34:2636‐2648. doi: 10.1093/eurheartj/eht210 PubMed DOI

Kociol RD, Cooper LT, Fang JC, PubMed DOI

Ammirati E, Frigerio M, Adler ED, PubMed DOI PMC

Pahuja M, Adegbala O, Mishra T, PubMed DOI

Tschöpe C, van Linthout S, Klein O, PubMed DOI PMC

Nasu T, Ninomiya R, Koeda Y, Morino Y. J‐PVAD Investigators, Impella device in fulminant myocarditis: Japanese Registry for Percutaneous Ventricular Assist Device (J‐PVAD) registry analysis on outcomes and adverse events. Eur Heart J Acute Cardiovasc Care 2024;13:275‐283. doi: 10.1093/ehjacc/zuad149 PubMed DOI

Baldetti L, Gramegna M, Beneduce A, PubMed DOI

Narain S, Paparcuri G, Fuhrman TM, Silverman RB, Peruzzi WT. Novel combination of Impella and extra corporeal membrane oxygenation as a bridge to full recovery in fulminant myocarditis. Case reports in critical care 2012;2012:1‐3. doi: 10.1155/2012/459296 PubMed DOI PMC

Bohné M, Chung DU, Tigges E, PubMed DOI PMC

Gawda R, Marszalski M, Sacha J, PubMed DOI PMC

Montero S, Huang F, Rivas‐Lasarte M, PubMed DOI

Temporary mechanical support in fulminant myocarditis: prognostic factors and clinical implications from the FULLMOON study